Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC YC W20 private credit investment marketplace with $1B+ in deals funded at up to 20% returns; democratizing institutional private debt access for accredited investors as global private debt fundraising hit $196B in 2024.
Percent is a New York City-based private credit investment marketplace — backed by Y Combinator (W20) — providing accredited investors and institutions with access to private credit investment opportunities (asset-backed lending, corporate credit, structured products) that have historically been accessible only to large institutional investors, having facilitated over $1 billion in total deal funding with potential annualized returns of up to 20%. Founded in 2018, Percent operates in the rapidly growing alternative investments market where private debt fundraising reached $196.1 billion globally in 2024, democratizing access to an asset class that represents 50% of asset management industry revenue despite comprising less than 20% of assets under management.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.